AMORPHOUS FORM OF CELL CYCLE INHIBITOR HAVING IMPROVED SOLUBILITY AND BIOAVAILABILITY

The present invention provides a method of preparing an amorphous, pharmaceutically active form of a compound of formula I which is substantially free of crystalline compound.

Saved in:
Bibliographic Details
Main Authors SHAH NAVNIT HARGOVINDAS, PHUAPRADIT WANTANEE, ALBANO ANTONIO A, SANDHU HARPREET K
Format Patent
LanguageEnglish
Published 24.10.2002
Edition7
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract The present invention provides a method of preparing an amorphous, pharmaceutically active form of a compound of formula I which is substantially free of crystalline compound.
AbstractList The present invention provides a method of preparing an amorphous, pharmaceutically active form of a compound of formula I which is substantially free of crystalline compound.
Author PHUAPRADIT WANTANEE
SANDHU HARPREET K
SHAH NAVNIT HARGOVINDAS
ALBANO ANTONIO A
Author_xml – fullname: SHAH NAVNIT HARGOVINDAS
– fullname: PHUAPRADIT WANTANEE
– fullname: ALBANO ANTONIO A
– fullname: SANDHU HARPREET K
BookMark eNqNyr0KwjAUQOEMOvj3Dhechaai4HibpuZC2luSptCpFImTtIX6_jjoAzgd-DhbsRqnMW5EwJJdbTh4KNiVwAUobS2oTlkNVBnKqGEHBluq7kBl7bjVOXi2ISNLTQdY5ZARY4tk8Wt7sX4OryUeft2JY6EbZU5xnvq4zMMjjvHdB58mSSovVylvKM__XR9xXjM-
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
Edition 7
ExternalDocumentID US2002156119A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2002156119A13
IEDL.DBID EVB
IngestDate Fri Jul 19 16:01:36 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2002156119A13
Notes Application Number: US20020120458
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20021024&DB=EPODOC&CC=US&NR=2002156119A1
ParticipantIDs epo_espacenet_US2002156119A1
PublicationCentury 2000
PublicationDate 20021024
PublicationDateYYYYMMDD 2002-10-24
PublicationDate_xml – month: 10
  year: 2002
  text: 20021024
  day: 24
PublicationDecade 2000
PublicationYear 2002
RelatedCompanies PHUAPRADIT WANTANEE
SANDHU HARPREET K
SHAH NAVNIT HARGOVINDAS
ALBANO ANTONIO A
RelatedCompanies_xml – name: SANDHU HARPREET K
– name: ALBANO ANTONIO A
– name: PHUAPRADIT WANTANEE
– name: SHAH NAVNIT HARGOVINDAS
Score 2.560854
Snippet The present invention provides a method of preparing an amorphous, pharmaceutically active form of a compound of formula I which is substantially free of...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title AMORPHOUS FORM OF CELL CYCLE INHIBITOR HAVING IMPROVED SOLUBILITY AND BIOAVAILABILITY
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20021024&DB=EPODOC&locale=&CC=US&NR=2002156119A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwEA9DRX3TqfgxJaD0rdiuXesehqRpayNtU_rF9jTSNg-CdMNV_PdNu033tLdwB0dy8MvdL8ldAHhiXGWGyTR5rHFF1k1eyUVRMbk0mVGNysrUjbZQOAgNL9Pfp6NpD3xua2G6PqE_XXNEgahS4L3p9uvl_yGW3b2tXD0XH0K0eHXTiS1t2XFLYHTJtiZORG2KJYwnWSKF8VoncgV1jARXOhSJtNniwcmtti5luRtU3DNwFAl7dXMOerzugxO8_XutD46DzZW3GG7Qt7oAGQpoHHk0S6DgbgGkLsSO70M8w74DSegRi6Q0hh7KSfgGSRDFNHdsmFA_s4hP0hlEoQ0tQlGOiI_Wskvw6Dop9mQxv_mfO-ZZsrsY7Qoc1IuaXwMo0KkyhRsjVbi4MBgTlHP4opTM1FpWoN-AwT5Lt_vVd-B0_ROKIg_1AThovr75vQjITfHQ-fEXBnqHOg
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwEA9jivNNp-LH1IDSt2K7dq17GNKmrY2mTekX29NIPx4E6Yar-O-bdpvuaW_hDo7k4Je7X5K7APDISplpOlPEsVJKoqqXhZhlBRNznWnFKC90VWsKhT1fcxP1bTqadsDntham7RP60zZH5IjKOd7rdr9e_h9iWe3bytVT9sFFixcnnljClh03BEYVLHNiB9SiSEBokkSCH651PFeQxwbnSgc8ydYbPNip2dSlLHeDinMCDgNur6pPQaes-qCHtn-v9cGRt7ny5sMN-lZnIDE8GgYuTSLIuZsHqQORTQhEM0RsiH0XmzimIXSNFPuvEHtBSFPbghEliYkJjmfQ8C1oYmqkBibGWnYOHhw7Rq7I5zf_c8c8iXYXo1yAbrWoyksAOTplJpXaSOYuzjTGOOUcPks505WGFahXYLDP0vV-9T3oubFH5gT77zfgeP0riiQO1QHo1l_f5S0PznV21_r0F4reii0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=AMORPHOUS+FORM+OF+CELL+CYCLE+INHIBITOR+HAVING+IMPROVED+SOLUBILITY+AND+BIOAVAILABILITY&rft.inventor=SHAH+NAVNIT+HARGOVINDAS&rft.inventor=PHUAPRADIT+WANTANEE&rft.inventor=ALBANO+ANTONIO+A&rft.inventor=SANDHU+HARPREET+K&rft.date=2002-10-24&rft.externalDBID=A1&rft.externalDocID=US2002156119A1